Kalgene Pharmaceuticals Inc. (“Kalgene”) is a Canadian company focused on the development of Oncology therapeutics and companion diagnostics. The company’s product pipeline is at various stages of research and development.
Lab-2-Clinic Solutions leverages its knowledge-base and experience in targeted therapeutics to deliver unique diagnostic and therapeutic solutions for unmet medical needs.
Snieckus Innovations is a Canadian custom synthesis group headed by Professor Victor Snieckus, a world-renowned synthetic chemist with extensive expertise in aromatic, heteroaromatic and directed metalation chemistry. They specialize in the synthesis of small molecules on milligram to gram scale to meet your needs.
BKIN Technologies develops next-generation, objective assessment systems to quantify sensorimotor performance and behaviour, supporting basic and clinical research on motor function.
Our team is comprised of experts in neuroscience, engineering, physiology, electronics, machining and software development. We work closely with basic and clinical researchers to integrate our technologies into their unique research programs to achieve their goals.
PARTEQ Innovations is the not-for-profit technology transfer office of Queen's University that works with Queen's researchers and the business and venture capital communities to bring early stage technologies to market. PARTEQ is housed in Innovation Park’s satellite wing in the Biosciences Complex on Queen’s main campus.
© 2012 Innovation Park at Queen's University. All rights reserved. Please contact us directly for permission to duplicate in whole or in part. Innovation Park at Queen's University is not responsible for the content of external internet websites linked from our website.
